Supernus Pharmaceuticals, Inc. SUPN
28.32 USD +0.17 (+0.59%)
Nov 3, 2026, 3:25 PM EST
28.31 Day range 31.62
28.31 52-week range 59.68
- YTD
- -43.03%
- 1 year
- -49.17%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 60.50 +113.7% upside
Now 28.32
- Target (low)
- 55.00
- Target (mean)
- 60.50
- Target (high)
- 67.00
Ratings (0m) 4 3 buy · 1 hold · 0 sell
- Strong buy0
- Buy3
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.04 | 0.84 – 1.23 | 0.8821 | +17.3% | 230.85M | +9.1% | 2 |
| Next quarter | 0.38 | 0.38 – 0.38 | -0.04 | +1050.0% | 248.60M | +19.7% | 1 |
| Current year | 2.77 | 2.63 – 2.90 | 2.40 | +15.4% | 884.42M | +23.0% | 2 |
| Next year | 4.17 | 4.17 – 4.17 | 2.77 | +50.8% | 1.02B | +15.3% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 9, 2026 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Dec 19, 2025 | Stifel | Maintained | Hold | Hold |
| Oct 29, 2025 | B of A Securities | Initiated | — | Buy |
| Oct 23, 2025 | TD Cowen | Maintained | Buy | Buy |
| Oct 9, 2025 | Piper Sandler | Upgrade | Neutral | Overweight |
| Sep 30, 2025 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Aug 29, 2025 | Piper Sandler | Maintained | Neutral | Neutral |
| Aug 6, 2025 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Feb 26, 2025 | Cantor Fitzgerald | Reiterated | Neutral | Neutral |
| Feb 19, 2025 | Cantor Fitzgerald | Downgrade | Overweight | Neutral |
| Sep 11, 2024 | Piper Sandler | Downgrade | Overweight | Neutral |
| Feb 28, 2024 | Piper Sandler | Maintained | Overweight | Overweight |
| Nov 9, 2023 | Piper Sandler | Maintained | Overweight | Overweight |
| Oct 25, 2023 | Piper Sandler | Maintained | Overweight | Overweight |
| May 10, 2023 | Piper Sandler | Maintained | Overweight | Overweight |
| Jan 23, 2023 | Piper Sandler | Maintained | — | Overweight |
| Aug 31, 2022 | Piper Sandler | Maintained | — | Overweight |
| Apr 13, 2021 | Jefferies | Upgrade | Hold | Buy |
| Jun 16, 2020 | Piper Sandler | Upgrade | Neutral | Overweight |
| Apr 16, 2020 | Stifel | Maintained | — | Hold |
| Nov 7, 2019 | Stifel | Downgrade | Buy | Hold |
| Nov 6, 2019 | Jefferies | Downgrade | Buy | Hold |
| Dec 17, 2018 | Mizuho | Maintained | Buy | Buy |
| Nov 12, 2018 | B. Riley Securities | Maintained | Buy | Buy |
| Sep 18, 2018 | Mizuho | Initiated | — | Buy |
| Aug 9, 2018 | Jefferies | Maintained | Buy | Buy |
| May 25, 2018 | Stifel | Maintained | Buy | Buy |
| Feb 1, 2018 | Berenberg | Initiated | — | Buy |
| Dec 4, 2017 | Janney Montgomery Scott | Upgrade | Neutral | Buy |
| Nov 8, 2017 | B. Riley Securities | Maintained | — | Buy |